Yuhan Corp. Signs 131 Billion Won API Supply Agreement With Global Pharmaceutical Company

Yuhan Corp. has signed a 131 billion won agreement to supply active pharmaceutical ingredients (API) to a global pharmaceutical company.

Yuhan Corp. disclosed on the 1st that it had entered into the API supply agreement in the form of a product supply arrangement. The contract value is 131,074,406,400 won, equivalent to 6.0% of the most recent revenue of 2.1866 trillion won based on the 2025 consolidated financial statements.

The counterparty is a global pharmaceutical company. At the counterparty’s request, Yuhan Corp. did not disclose its name and deferred the disclosure to protect business confidentiality. The deferral period runs through May 31, 2028.

The contract runs from the date of the announcement through May 31, 2028. The end date may change by mutual agreement between the two companies. The sales and supply region has not yet been determined.

The contract value is $95.424 million, calculated using the initial posted exchange rate on Sept. 1, 2026, of 1,373.60 won per dollar. There is no contract deposit or advance payment. The contract date is the date the purchase order was received.